MULTICASE INC in Cleveland, Ohio
Services Offered:
Research
Software Development
In Silico
Safety Of Chemicals
Drug Design
Environment
Qsar
Carcinogenicity
Mutagenicity
Toxicity
Metabolism
Adme
Computer Models
Expert Systems
Web Results:
- Suman Chakravarti
- Suman Chakravarti, Ph.D. (Medicinal and Pharmaceutical Chemistry) Position: Vice President and Chief Scientific Officer Phone: (216) 831-3740 Fax: (216) 831-3742 E-mails: chakravarti 'at' multicase.com Areas of Expertise: Dr Chakravarti has a Ph.D. in Medicinal and Pharmaceutical Chemistry with spec...
- Skin, eye irritations,...
- Skin, eye irritations, allergies Module ID Description # of Compounds A30 Sensory Irritation 226 A31 Eye Irritation Draize TestAvon & Carpenter - in rabbit 618 A32 Eye Irritation Draize Test Avon's compounds only- in rabbit 106 A33 Allergic Contact Dermatitis 1033 A34 Human acute dermatite 141 C...
- Cytotoxicity
- Cytotoxicity Module ID Description # of Compounds AB0 anti-HIV agents (ctf: LD50=210uM AF2) 211 AB1 NTP Cellular Toxicity 190 AB2 Tumor cytotoxicity GI50 from Nat'l Cancer Inst. NCI/DTP 2035 Click to request information [Home] [Up] [Feedback] [Contents] [Search] [Contacts] [Publications] [FAQ] [Supp...
- CDER RCA
- MultiCASE Inc and Center for Drug Evaluation and Research of FDA have signed Research Cooperative Agreement Enhancement of In Silico Decision Support Tools for theEvaluation of Drug Safety . The FDA and MultiCASE Inc. will work jointly under this 5-year research collaboration agreement (RCA) to dev...
- recommendations
- ICH M7 Step 2 guidance specifies requirements to a genetoxcity evaluations of impurities. MultiCASE Inc suggest to use the following test algorithm and strategy to comply with the ICH M7 guideline Step 1 Using CASE Ultra Neighborhood analyses tool test RCA rodent carcinogenicity set for exact match ...
Business Information:
In Business Since: | 1995 |
Business Sector: | Residential, Commercial |